Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “CTOR”

756 pharma patents match "CTOR" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 756
Index total 30,257
Page 21 / 32

Quick answer

This filtered view shows 756 pharmaceutical patents matching "CTOR" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

756 results for “CTOR” · 30,257 patents in full index Clear search

  1. US 8449875

    Targeting pseudotyped retroviral vectors

    The Regents of the University of California · Granted May 28, 2013 · Expires May 23, 2033

    granted
  2. US 8440431

    TAL effector-mediated DNA modification

    Regents of the University of Minnesota · Granted May 14, 2013 · Expires May 9, 2033

    granted
  3. US 8440432

    Tal effector-mediated DNA modification

    Regents of the University of Minnesota · Granted May 14, 2013 · Expires May 9, 2033

    granted
  4. US 8420619

    Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein

    Ceregene, Inc. · Granted Apr 16, 2013 · Expires Apr 11, 2033

    granted
  5. US 8409548

    Administration of growth factors for the treatment of CNS disorders

    The Regents of the University of California · Granted Apr 2, 2013 · Expires Mar 28, 2033

    granted
  6. US 8394764

    Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Mar 12, 2013 · Expires Mar 7, 2033

    granted
  7. US 8383388

    Modified coagulation factor IX polypeptides and use thereof for treatment

    Catalyst Biosciences, Inc. · Granted Feb 26, 2013 · Expires Feb 21, 2033

    granted
  8. US 8372800

    Albumin-free factor VIII formulations

    UNIVERSITY OF CONNECTICUT · Granted Feb 12, 2013 · Expires Feb 7, 2033

    granted
  9. US 8367074

    Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 5, 2013 · Expires Jan 31, 2033

    granted
  10. US 8349800

    Von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage

    Nektar Therapeutics · Granted Jan 8, 2013 · Expires Jan 3, 2033

    granted
  11. US 8343499

    Anti-arthropod vector vaccines, methods of selecting and uses thereof

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jan 1, 2013 · Expires Dec 27, 2032

    granted
  12. US 8334273

    Compositions and methods for inhibiting expression of factor VII gene

    Alnylam Pharmaceuticals, Inc. · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted
  13. US 8323662

    Methods useful for generating highly mannosylated pseudotyped lentiviral vector particles comprising a Vpx protein

    IMMUNE DESIGN CORP. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  14. US 8323961

    HIV vaccines based on adenoviral vectors encoding Env from multiple clades of HIV

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  15. US 8323634

    Stable formulations of highly concentrated recombinant human albumin-human granulocyte colony stimulating factor

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 4, 2012 · Expires Nov 29, 2032

    granted
  16. US 8309071

    Foamy viral envelope genes

    Vectoria Forschungsforderungs Verein E.V. · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  17. US 8309355

    Methods of treating Parkinson's disease using viral vectors

    The Regents of the University of California · Granted Nov 13, 2012 · Expires Nov 8, 2032

    granted
  18. US 8263095

    Methods of use for peptides having activities of insulin like growth factor-1

    CAREGEN CO., LTD. · Granted Sep 11, 2012 · Expires Sep 6, 2032

    granted
  19. US 8247536

    Factor VIII compositions

    Nektar Therapeutics · Granted Aug 21, 2012 · Expires Aug 16, 2032

    granted
  20. US 8242093

    Rescue of photoreceptors by intravitreal administration of an expression vector encoding a therapeutic protein

    Ceregene, Inc. · Granted Aug 14, 2012 · Expires Aug 9, 2032

    granted
  21. US 8221138

    Audio jack connector with improved soldering tail

    Hon Hai Precision Ind. Co., Ltd. · Granted Jul 17, 2012 · Expires Jul 12, 2032

    granted
  22. US 8206715

    Antibodies that bind colony stimulating factor 1 receptor (CSF1R)

    Five Prime Therapeutics, Inc. · Granted Jun 26, 2012 · Expires Jun 21, 2032

    granted
  23. US 8188049

    Peptides having activities of epidermal growth factor and its uses

    CAREGEN CO., LTD. · Granted May 29, 2012 · Expires May 24, 2032

    granted
  24. US 8187872

    Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein

    IMMUNE DESIGN CORP. · Granted May 29, 2012 · Expires May 24, 2032

    granted